Review for "A randomised Phase I study of the safety, tolerability, pharmacokinetics and pharmacodynamics of <scp>BI</scp> 456906, a dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist, in healthy Japanese men with overweight/obesity"

Abstract

Abstract is not available.